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Abstract 
Background: Ligusticum chuanxiong Hort. (Chuanxiong) is a well‑known Chinese medicine, and studies on its chemi‑
cal constituents are important for explaining its mechanism of action and quality control. This study aims to investi‑
gate the chemical constituents of the dried rhizome of. L. chuanxiong.
Methods: The dried rhizome of L. chuanxiong was extracted with 60 % ethanol, and the concentrated extract was 
isolated by silica gel, octadecyl silane, and Sephadex LH‑20 columns, followed by preparative/semipreparative high‑
performance liquid chromatography (HPLC) to obtain the pure chemical constituents. The structures of the constitu‑
ents were elucidated by HR‑ESI‑MS, UV, IR, 1D NMR, and 2D NMR methods. Enantiomeric separation was achieved by 
a chiral HPLC method. The absolute configuration was determined by the modified Mosher’s method.
Results: Six novel phthalide derivatives, (+)/(−)‑chuanxiongins A–F (1–6), together with four known phthalides 
(7–10) were isolated from Chuanxiong. All of the new compounds (1–6) were present as pairs of enantiomers. Enan‑
tiomeric separation of 1 was successfully achieved by HPLC on a chiral column. The absolute configuration of (−)‑1 
was determined by a modified Mosher’s method.
Conclusion: The six novel phthalide derivatives (1–6) isolated from Chuanxiong were phthalide fatty acid esters that 
were structurally analogous and characterized by fatty acid acylation at 6‑OH or 7‑OH.
Keywords: Ligusticum chuanxiong, Chuanxiong, Phthalide fatty acid esters, New subtype of phthalides, 
Chuanxiongins
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Background
The dried rhizome of Ligusticum chuanxiong Hort. 
(Chuanxiong) has been used for the treatment of men-
strual disorders in Chinese medicine [1]. Chuanxiong has 
the functions of activating blood flow, expelling wind, and 
relieving pain associated with blood (xue) and qi stagna-
tion [2]. Previous phytochemical studies on Chuanx‑
iong isolated some phthalides (monomeric and dimeric 
phthalides) [3–6], alkaloids [7], phenolic acids [8], cera-
mides, and cerebrosides [9]. Among them, phthalides as 
the characteristic constituents had bioactivities including 
vasodilatation [10], decreased platelet aggregation [11], 
analgesia [12], anti-inflammation [13, 14], and butyryl-
choline esterase inhibition [15]. The chemical studies on 
the constituents of Chuanxiong and identification of new 
constituents are beneficial for explaining how it exerts its 
effects and form the foundation for its quality control. 
This study aims to investigate the chemical constituents 
of Chuanxiong and identify new constituents.
Methods
General experimental procedures
Optical rotations were obtained on a JASCO P-1020 digi-
tal polarimeter (JASCO Corporation, Tokyo, Japan). UV 
spectra were recorded with a JASCO V-550 UV/Vis spec-
trometer (JASCO Corporation, Tokyo, Japan). IR spectra 
were acquired using a JASCO FT/IR-480 plus spectrom-
eter (JASCO Corporation, Tokyo, Japan). CD spectra 
were obtained on a JASCO J-810 spectropolarimeter at 
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room temperature. 1D and 2D spectra were measured 
with a Bruker AV300/400 spectrometer in CDCl3 
(δH = 7.26 ppm, δC = 77.2 ppm) or C5D5N (tetramethyl-
silane (TMS) as internal standard) solution. ESI-MS spec-
tra were acquired on a FINNIGAN LCQ Advantage MAX 
mass spectrometer. HR-ESI-MS spectra were taken on a 
Waters Snapt G2 mass spectrometer. Analytical HPLC 
was performed on a Waters 2695 HPLC system equipped 
with a UV detector and a reversed-phase column (5 µm; 
i.d. 250  ×  4.6  mm; Cosmosil). HPLC separations were 
performed using a Waters 1515 system equipped with a 
UV detector and a reversed-phase semipreparative col-
umn (5 μm; i.d. 250 × 10 mm; Cosmosil) or preparative 
column (5 μm; i.d. 250 × 20 mm; Cosmosil). Chiral sepa-
ration was achieved by HPLC on a Dionex 3000 series 
pump equipped with a UV detector and a Lux TF Cellu-
lose-2 column (3  µm; i.d. 250 ×  4.6  mm; Phenomenex). 
Silica gel (200–300 mesh; Qingdao Marine Chemical Ltd., 
China), octadecyl silane (ODS) (YMC Ltd., Japan), and 
Sephadex LH-20 (Amersham Pharmacia Biotech, Swe-
den) were used for column chromatography. Mosher’s 
reagent was purchased from Alfa Aesar (England).
Plant material
The dried rhizome of L. chuanxiong Hort. was supplied by 
Sichuan Neautus Traditional Chinese Medicine Co. Ltd. 
(China) in 2012, and identified by Yue-Cheng Li (Sichuan 
Institute for Food and Drug Control) by characteristic 
identification, microscopic identification, and the physics 
and chemistry identification according to Chinese phar-
macopoeia [1]. A voucher specimen (LICH-2012-SC) was 
deposited in the Institute of Traditional Chinese Medicine 
and Natural Products, Jinan University (China).
Extraction and isolation
The dried rhizome of L. chuanxiong Hort. (18.0 kg) was 
cut into small pieces and extracted with 60 % ethanol (70 
L × 2 h × 2). The concentrated extract (5.69 kg) was sus-
pended in H2O (13 L) and successively partitioned with 
EtOAc and n-BuOH (each 10 L  ×  4). The EtOAc layer 
(480 g) was loaded onto a silica gel column (8 × 75 cm) 
and eluted with a cyclohexane–EtOAc gradient (100:0, 
99:1, 98:2, 95:5, 90:10, 80:20, 70:30, 60:40, 0:100, v/v, 
each 35 L) to produce 13 fractions (Fr.1–Fr.13). Fr.2 
(20.0  g) was loaded onto an ODS column (4  ×  35  cm) 
and eluted with a MeOH–H2O gradient (40:60, 50:50, 
60:40, 70:30, 80:20, 100:0, v/v, each 1 L) to give 5 frac-
tions (Fr.2.1–Fr.2.5). Fr.2.2 (397  mg) was separated by 
semipreparative HPLC (45 % MeOH–H2O, 3.5 mL/min) 
to afford compounds 7 (tR =  30.2  min; 32.4  mg) and 8 
(tR = 26.4 min; 25.9 mg). Fr.8 (17.0 g) was applied to an 
ODS column (4  ×  44  cm) and eluted with a MeOH–
H2O gradient (10:90, 30:70, 40:60, 50:50, 60:40, 70:30, 
80:20, 90:10, 100:0, v/v, each 2 L) to give 17 subfractions 
(Fr.8.1–8.17). Fr.8.6 (1.09 g) was separated on a Sephadex 
LH-20 column (2  ×  90  cm) by elution with a MeOH–
H2O gradient (50:50, 60:40, 100:0, v/v, each 0.5 L) to 
yield 8 subfractions. Subfraction Fr.8.6.6 was purified by 
semipreparative HPLC (50  % MeOH-H2O, 4  mL/min) 
to yield compounds 9 (tR  =  18.6  min; 9.8  mg) and 10 
(tR = 22.1 min; 17.3 mg). Fr.8.17 (0.98 g) was separated on 
a Sephadex LH-20 column (3 × 120 cm) using MeOH to 
yield 6 subfractions. Subfraction Fr.8.17.3 (899.0 mg) was 
further purified by preparative HPLC (87 % MeOH–H2O, 
8 mL/min) to yield compounds 1 (tR = 156 min; 36.0 mg), 
2 (tR = 147 min; 10.7 mg), 3 (tR = 173 min; 19.1 mg), 4 
(tR = 164 min; 4.0 mg), 5 (tR = 114 min; 137.0 mg), and 
6 (tR = 107 min; 33.6 mg). Chiral analyses of compounds 
1–6 (95  % MeOH–H2O, 0.7  mL/min) and 7–8 (75  % 
MeOH–H2O, 0.5 mL/min) were conducted on a Lux TF 
Cellulose-2 column. For compound 1, chiral separation 
was performed on the same chiral column (95 % MeOH–
H2O, 0.7 mL/min) to yield (+)-1 (tR = 11.8 min; 1.0 mg) 
and (−)-1 (tR = 16.2 min; 1.0 mg).
Results
Six novel phthalide derivatives, (+)/(−)-chuanxiongins 
A–F (1–6), a new natural product (9), and three known 
phthalides (7, 8, and 10) were isolated from the 60 % etha-
nol extract of Chuanxiong (Fig. 1). Compounds 1–8 were 
obtained as pairs of enantiomers. Compound 1 was suc-
cessfully resolved by chiral HPLC to afford (+)-1 and (−)-1. 
Their structures and absolute configuration were elucidated 
on the basis of spectroscopic data, circular dichroism (CD) 
analyses, and the modified Mosher’s method.
Physicochemical data of new compounds
Chuanxiongin A (1). Colorless oil; UV (MeOH) λmax (log 
ε) 204 (4.03), 275 (4.09) nm; IR (KBr) νmax 3446, 2955, 
2930, 2858, 1742, 1458 cm−1; 1H NMR (CDCl3, 300 MHz) 
and 13C NMR (CDCl3, 75 MHz), see Tables 1 and 2; HR-
ESI-MS m/z 463.3421 [M  +  H]+ (calcd for C28H47O5, 
463.3423).
(+)‑Chuanxiongin A [(+)‑1] [α]17D  +  35.5 (c 0.40, 
MeOH); CD (MeOH) λmax (Δε) 249.2 (-0.12), 220.6 
(+0.72) nm.
(−)‑Chuanxiongin A [(−)‑1] [α]17D-31.6 (c 0.35, 
MeOH); CD (MeOH) λmax (Δε) 251.3 (–0.13), 221.5 
(+0.63) nm.
(S)‑MTPA ester of (−)‑1 [(−)‑1‑a] 1H NMR (C5D5N, 
400  MHz): δH 2.6001 (2H, m, H-4), 2.2082 (2H, over-
lapped, H-5), 5.7335 (1H, m, H-6), 6.2526 (1H, d, 
J = 5.5 Hz, H-7).
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(R)‑MTPA ester of (−)‑1 [(−)‑1‑b] 1H NMR (C5D5N, 
400 MHz): δH 2.5415 (1H, overlapped, H-4), 2.3910 (1H, 
dt, J = 18.5, 6.1 Hz, H-4), 2.1479 (2H, overlapped, H-5), 
5.7616 (1H, m, H-6), 6.3017 (1H, d, J = 5.1 Hz, H-7).
Chuanxiongin B (2) Colorless oil; UV (MeOH) λmax (log 
ε) 205 (4.00), 275 (3.96) nm; IR (KBr) νmax 3446, 2957, 
2925, 2854, 1771, 1741, 1457  cm−1; 1H NMR (CDCl3, 
300 MHz) and 13C NMR (CDCl3, 75 MHz), see Tables 1 
Fig. 1 Structures of compounds 1–10
Table 1 1H and 13C NMR data for the phthalide nucleus of 1–8 (CDCl3, δ in ppm, J in Hz)*
* Indiscernible signals owing to overlapping or having complex multiplicity are reported without designating multiplicity
Position 1/3/5 2/4/6 7 8
δC δH δC δH δC δH δC δH
1 167.7 168.9 169.6 169.4
3 148.2 148.3 148.3 148.1
3a 155.2 152.9 153.7 153.3
4 17.8 2.48 (dt, 18.5, 5.4) 2.62 (dt, 18.5, 6.9) 18.3 2.51 18.9 2.41 2.63 (dt, 18.5, 5.8) 19.1 2.51
5 25.8 1.99 23.1 2.00 2.10 25.5 1.82 2.08 26.5 1.88 2.06
6 68.5 4.08 (dt, 6.0, 3.9) 72.3 5.10 67.9 4.00 71.7 3.93
7 67.5 5.53 (d, 3.9) 63.4 4.56 (d, 3.9) 63.0 4.59 (d, 3.0) 67.6 4.44 (d, 5.5)
7a 122.3 125.6 125.7 125.9
8 114.3 5.31 (t, 7.9) 114.5 5.31 (t, 7.9) 114.7 5.30 (t, 7.9) 114.6 5.28 (t, 7.9)
9 28.2 2.36 28.3 2.37 28.2 2.34 28.2 2.33
10 22.4 1.50 22.4 1.51 22.4 1.49 22.4 1.47
11 13.9 0.95 (t, 7.4) 13.9 0.96 (t, 7.4) 13.9 0.94 (t, 7.4) 13.9 0.93 (t, 7.3)
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and 2; HR-ESI-MS m/z 463.3435 [M  +  H]+ (calcd for 
C28H47O5, 463.3423).
Chuanxiongin C (3) Colorless oil; UV (MeOH) λmax 
(log ε) 205 (3.83), 275 (3.81) nm; IR (KBr) νmax 3422, 
2956, 2926, 2854, 1774, 1741, 1459, 724 cm−1; 1H NMR 
(CDCl3, 300 MHz) and 13C NMR (CDCl3, 75 MHz), see 
Tables  1 and 2; HR-ESI-MS m/z 511.3394 [M  +  Na]+ 
(calcd for C30H48O5Na, 511.3399).
Chuanxiongin D (4) Colorless oil; UV (MeOH) λmax 
(log ε) 204 (3.96), 275 (4.00) nm; IR (KBr) νmax 2956, 
2926, 2855, 1771, 1742, 1457  cm−1; 1H NMR (CDCl3, 
400 MHz) and 13C NMR (CDCl3, 100 MHz), see Tables 1 
and 2; HR-ESI-MS m/z 489.3579 [M  +  H]+ (calcd for 
C30H49O5, 489.3580).
Chuanxiongin E (5) Colorless oil; UV (MeOH) λmax (log 
ε) 205 (3.91), 274 (3.45) nm; IR (KBr) νmax 3421, 2956, 
2929, 2857, 1732, 1716, 1457  cm−1; 1H NMR (CDCl3, 
300 MHz) and 13C NMR (CDCl3, 75 MHz), see Tables 1 
and 2; HR-ESI-MS m/z 509.3250 [M  +  Na]+ (calcd for 
C30H46O5Na, 509.3243).
Chuanxiongin F (6) Colorless oil; UV (MeOH) λmax (log 
ε) 205 (4.04), 273 (3.53) nm; IR (KBr) νmax 3446, 2956, 
2927, 2856, 1733, 1718, 1457  cm−1; 1H NMR (CDCl3, 
300 MHz) and 13C NMR (CDCl3, 75 MHz), see Tables 1 




Chuanxiongin A (1), obtained as a colorless oil, was 
assigned the molecular formula C28H46O5 according 
to its HR-ESI-MS at m/z 463.3421 [M +  H]+ (calcd for 
463.3423). The 1H-NMR spectral data (Tables 1 , 2) of 1 
were similar to those of senkyunolide H (7) [5], expect for 
the appearance of typical fatty acid signals (δH 1.22–2.32 
and δC 22.8–34.4). Indeed, the presence of the senkyu-
nolide H moiety was further confirmed by detailed anal-
yses in 1H-1H COSY, HSQC, and HMBC experiments 
(Fig.  2). On the basis of the mass spectral information, 
the fatty acid moiety was deduced as palmitic acid. The 
above spectral data suggested that 1 might be the prod-
uct of 7 acylated at 6-OH or 7-OH with a long-chain fatty 
Table 2 1H and 13C NMR data for the fatty acid moieties of 1–6 (CDCl3, δ in ppm, J in Hz)*
* Indiscernible signals owing to overlapping or having complex multiplicity are reported without designating multiplicity
Position Palmitoyl for 1 and 2 Oleoyl for 3 and 4 Linoleoyl for 5 and 6
δC δH δC δH δC δH






2′ 34.4 2.32 for 1
2.29 for 2




34.4 2.33 for 5
2.29 for 6
3′ 25.0 1.62 for 1
1.59 for 2
25.0 25.0 1.63 for 5
1.59 for 6
4′ 29.2–29.8 1.22–1.32 29.2–29.9 1.24–1.37 29.2–29.7 1.24–1.37
5′ 29.2–29.8 1.22–1.32 29.2–29.9 1.24–1.37 29.2–29.7 1.24–1.37
6′ 29.2–29.8 1.22–1.32 29.2–29.9 1.24–1.37 29.2–29.7 1.24–1.37
7′ 29.2–29.8 1.22–1.32 29.2–29.9 1.24–1.37 29.2–29.7 1.24–1.37
8′ 29.2–29.8 1.22–1.32 27.4 2.01 27.3 2.04
9′ 29.2–29.8 1.22–1.32 129.9 5.35 130.2 5.36
10′ 29.2–29.8 1.22–1.32 130.1 5.35 128.2 5.33
11′ 29.2–29.8 1.22–1.32 27.3 2.01 25.8 2.76 (t, 6.0)
12′ 29.2–29.8 1.22–1.32 29.2–29.9 1.24–1.37 128.1 5.33
13′ 29.2–29.8 1.22–1.32 29.2–29.9 1.24–1.37 130.4 5.36
14′ 32.1 1.24 29.2–29.9 1.24–1.37 27.3 2.04
15′ 22.8 1.27 29.2–29.9 1.24–1.37 29.2–29.7 1.24–1.37
16′ 14.3 0.87 (t, 6.7) 32.0 1.25 31.7 1.28
17′ 22.8 1.29 22.7 1.29
18′ 14.2 0.87 (t, 6.7) 14.2 0.88 (t, 6.8)
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acyl moiety. Furthermore, from the significant downfield 
shift [δH 5.53 (d, J = 3.9 Hz, H-7)] in comparison with 7, 
the palmitoyl group was assigned to 7-OH via an ester 
bond. This was supported by the key HMBC correlation 
from H-7 to the ester carbonyl at δC 174.0 of the palmi-
toyl group. The relative stereochemistry of 1 was found 
to be the same as 7 (cis-oriented) owing to the small J6,7 
value of 3.9 Hz, as well as the carbon chemical shifts of 
C-6 and C-7 [16]. Thus, the structure of 1 was elucidated 
as (4R*,5S*,Z)-1-butylidene-5-hydroxy-3-oxo-1,3,4,5,6,7-
hexahydroisobenzofuran-4-yl palmitate, and designated 
chuanxiongin A.
The optical rotation value of 1 was almost zero, indi-
cating a racemic nature, which was in accordance with 
the appearance of two peaks in the chiral HPLC analy-
sis (Fig.  3). The chiral resolution of 1 by chiral HPLC 
afforded a pair of anticipated enantiomers, (+)-1 and 
(−)-1, which were opposite in terms of their opti-
cal values and CD curves (Fig.  4). The absolute con-
figuration of the enantiomer (−)-1 was established 
by the modified Mosher’s method [17]. A solution of 
(−)‑1 (0.5  mg) in C5D5N (0.5  mL) was treated with 
Fig. 2 Key HMBC and 1H‑1H COSY correlations of 1
Fig. 3 Chiral HPLC analytical chromatograms of compounds 1–8. The retention times (min) for the two peaks of compounds 1–6 (95 % MeOH‑H2O, 
0.7 mL/min; 276 nm) and 7–8 (75 % MeOH‑H2O, 0.5 mL/min; 276 nm) are marked on each chromatogram. The letters a–h successively stand for the 
profiles of 1–8
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(R)-α-methoxy-α-trifluoromethyl-α-phenylacetyl chlo-
ride ((R)-MTPA chloride) (10 μL) under an atmosphere 
of nitrogen in an NMR tube. The mixture was stirred at 
room temperature for 4 h to obtain the (S)-MTPA ester 
[(−)-1‑a]. The same procedure was used to prepare the 
(R)-MTPA ester [(−)-1‑b] with (S)-MTPA chloride. The 
Δδ values of the (S)- and (R)-MTPA esters [(−)-1‑a and 
(−)-1‑b, respectively] indicated the R configuration for 
C-6 (Fig.  5). Therefore, the absolute configurations of 
(+)-1 and (−)-1 were respectively established as 6S, 7R 
and 6R, 7S.
Chuanxiongin B (2) had the same molecular formula 
of C28H46O5 as 1, obtained from its HR-ESI-MS at m/z 
463.3435 [M +  H]+, and exhibited similar physical and 
NMR data (Tables 1 and 2) to those of 1, except for the 
large upfield shift of H-7 and downfield shift of H-6, indi-
cating the position of esterification at 6-OH instead of 
7-OH. This deduction was further confirmed by the key 
HMBC correlation from H-6 to the ester carbonyl at δC 
173.3. Therefore, the structure of 2 was deduced as sen-
kyunolide H 6-palmitate, with the systematic name of 
(4R*,5S*,Z)-1-butylidene-4-hydroxy-3-oxo-1,3,4,5,6,7-
hexahydroisobenzofuran-5-yl palmitate. It was desig-
nated with the common name chuanxiongin B.
Chuanxiongin C (3), a colorless oil, was assigned with 
the molecular formula C30H48O5 by HR-ESI-MS (m/z 
511.3394 [M + Na]+). The 1H- and 13C-NMR data of the 
phthalide moiety in 3 were essentially identical to those of 
1 (Table 1). The only difference was an oleoyl group in 3 
instead of a palmitoyl group in 1. The presence of the ole-
oyl group was further confirmed on the basis of the mass 
and NMR spectral data [18]. Accordingly, compound 3 
was determined as (4R*,5S*,Z)-1-butylidene-5-hydroxy-
3-oxo-1,3,4,5,6,7-hexahydroisobenzofuran-4-yl oleate, 
and designated chuanxiongin C.
Chuanxiongin D (4) was determined to have the same 
molecular formula as 3 on the basis of the HR-ESI-MS 
(m/z 489.3579 [M + H]+) and NMR spectra. The 1H- and 
13C-NMR spectral data of 4 showed the signals for ole-
oyl and senkyunolide H moieties. In the HMBC spec-
trum, the proton H-6 showed a long-range correlation 
with the ester carbonyl, indicating that the fatty acid 
chain was linked to 6-OH. Thus, 4 was determined as 
(4R*,5S*,Z)-1-butylidene-4-hydroxy-3-oxo-1,3,4,5,6,7-
hexahydroisobenzofuran-5-yl oleate, and designated 
chuanxiongin D.
On the basis of the HR-ESI-MS (m/z 509.3250 
[M + Na]+ for 5; 509.3243 [M + Na]+ for 6) and NMR 
spectra, the molecular formula of chuanxiongin E (5) 
and chuanxiongin F (6) was determined to be C30H46O5. 
According to the NMR evidence, 5 and 6 were also fatty 
acid-acylated derivatives of senkyunolide H (7). Moreo-
ver, the acylating fatty acid moiety was deduced to be a 
linoleoyl group from the mass spectral data, as well as 
a comparison of the 13C NMR data with previous lit-
erature [18]. Similarly, the HMBC correlations and con-
siderable acylation shifts implied that in the cases of 5 
and 6, a linoleoyl group was attached at the 7-OH and 
6-OH positions, respectively. Thus, 5 and 6 were deter-
mined as (4R*,5S*,Z)-1-butylidene-5-hydroxy-3-oxo-
1,3,4,5,6,7-hexahydroisobenzofuran-4-yl linoleate (5) and 
(4R*,5S*,Z)-1-butylidene-4-hydroxy-3-oxo-1,3,4,5,6,7-
hexahydroisobenzofuran-5-yl linoleate (6), and des-
ignated chuanxiongin E (5) and chuanxiongin F (6), 
respectively.
Compounds 7 and 8 were identified as senkyunolide H 
(7) [5] and senkyunolide I (8) [5] by comparisons of their 
physiochemical properties and spectral data with those 
reported in the literature.
Similarly, the optical rotation values of compounds 
2–8 were almost zero, suggesting that they were also pre-
sent as pairs of enantiomers, as further confirmed by the 
observations of two separated peaks in the chiral chro-
matographic analysis experiment (Fig. 3).


















Fig. 4 CD spectra of (+)‑1 and (−)‑1
Fig. 5 The Δδ values of the (S)‑ and (R)‑MTPA esters ((−)‑1-a and 
(−)‑1-b) indicating the R configuration of C‑6 in (−)‑1
Page 7 of 7Yang et al. Chin Med  (2016) 11:10 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Compounds 9 and 10 were elucidated as 6-hydroxy-
senkyunolide B (9) [19, 20] and senkyunolide C (10) [21] 
based on comparisons with published spectroscopic data.
Chuanxiongins A–F (1–6) comprise a new subtype of 
phthalides and represent a new class of chemical constit-
uents in Chuanxiong. The discovery of them warranted 
further research on its mechanism of action and use for 
quality control.
Conclusions
Six novel phthalide derivatives (1–6) isolated from 
Chuanxiong were phthalide fatty acid esters that were 
structurally analogous and characterized by fatty acid 
acylation at 6-OH or 7-OH.
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